Professor Manuel Mayr
British Heart Foundation Professor of Cardiovascular Proteomics
Research interests
- Cardiovascular
Biography
Manuel Mayr qualified in Medicine from the University of Innsbruck (Austria) in 1999. He then moved to London to undertake a PhD. Upon completion of his PhD, he achieved promotion to Professor in 2011. He has been awarded a prestigious British Heart Foundation Personal Chair in 2017. His academic achievements have been recognised by the inaugural Michael Davies Early Career Award of the British Cardiovascular Society (2007), the inaugural Bernard and Joan Marshall Research Excellence Prize of the British Society for Cardiovascular Research (2010), and the Outstanding Achievement Award by the European Society of Cardiology Council for Basic Cardiovascular Science (2013).
Research
Vascular Proteomics
Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
News
Researchers from King's identify new potential molecular mechanism in obesity
This study identifies neuronal growth regulator 1 (Negr1) as a factor that promotes neuronal growth and protects from the excessive fat accumulation...
Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits
Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.
Protein identified as new therapeutic anti-viral target for COVID-19
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new...
Quest for biomarkers in blood samples of COVID-19 patients to better understand host response
Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...
Research
Vascular Proteomics
Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
News
Researchers from King's identify new potential molecular mechanism in obesity
This study identifies neuronal growth regulator 1 (Negr1) as a factor that promotes neuronal growth and protects from the excessive fat accumulation...
Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits
Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.
Protein identified as new therapeutic anti-viral target for COVID-19
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new...
Quest for biomarkers in blood samples of COVID-19 patients to better understand host response
Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...